| Numara | Eser | Yazarlar | Benzer Yayınlar | PubMed Tanımlayıcısı |
|---|---|---|---|---|
| 1 | A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19. | Yekedüz E, Utkan G, Ürün Y. | Eur J Cancer. 2020 Dec;141:92-104. doi: 10.1016/j.ejca.2020.09.028. Epub 2020 Oct 6. | PMID: 33130550 |
| 2 | mRNA-based COVID-19 vaccines appear not to increase immune events in cancer patients receiving immune checkpoint inhibitors. | Yekedüz E, Ayasun R, Köksoy EB, Utkan G, Ürün Y, Akbulut H. | Future Virol. 2021 Aug:10.2217/fvl-2021-0166. doi: 10.2217/fvl-2021-0166. Epub 2021 Sep 2. | PMID: 34531922 |
| 3 | In the Age of Immunotherapy, How Can We Translate the CARMENA Results into Practice? | Yekedüz E, Süer E, Utkan G, Baltacı S, Ürün Y. | Eur Urol Oncol. 2021 Jun;4(3):515-516. doi: 10.1016/j.euo.2021.02.009. Epub 2021 Mar 10. | PMID: 33714722 |
| 4 | Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle? | Yekedüz E, Utkan G, Ürün Y. | J Oncol Pharm Pract. 2021 Mar;27(2):450-452. doi: 10.1177/1078155220988753. Epub 2021 Jan 20. | PMID: 33470163 |
| 5 | Neurotoxicities of novel non-steroidal anti-androgens for prostate cancer: A systematic review and meta-analysis. | Bakouny Z, Yekedüz E, Braun DA, Berchuck JE, Hirsch L, Utkan G, Lee Y, Trinh QD, Choueiri TK, Ürün Y. | Crit Rev Oncol Hematol. 2021 Oct;166:103463. doi: 10.1016/j.critrevonc.2021.103463. Epub 2021 Aug 27. | PMID: 34461269 |
| 6 | Expanding armamentarium in advanced prostate cancer management: are all novel antiandrogens the same? | Yekedüz E, Utkan G, Kanesvaran R, Ürün Y. | Prostate Int. 2021 Mar;9(1):1-5. doi: 10.1016/j.prnil.2020.03.002. Epub 2020 Mar 31. | PMID: 33912507 |
| 7 | A clinical dilemma amid COVID-19 pandemic: missed or encountered diagnosis of cancer? | Yekedüz E, Karcıoğlu AM, Utkan G, Ürün Y. | Future Oncol. 2020 Sep;16(25):1879-1881. doi: 10.2217/fon-2020-0501. Epub 2020 Jun 21. | PMID: 32564611 |
| 8 | Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer. | Yazici O, Dogan M, Ozal G, Aktas SH, Demirkazik A, Utkan G, Senler FC, Icli F, Akbulut H. | Comb Chem High Throughput Screen. 2021;24(8):1229-1235. doi: 10.2174/1386207323666200902135349. | PMID: 32881660 |
| 9 | Vaccination in oncology practice and predictors. | Alkan A, Karcı E, Yaşar A, Tuncay G, Köksoy EB, Ürün M, Şenler FÇ, Demirkazık A, Utkan G, Akbulut H, Ürün Y. | Support Care Cancer. 2017 Sep;25(9):2677-2682. doi: 10.1007/s00520-017-3675-y. Epub 2017 Mar 22. | PMID: 28331981 |
| 10 | ctDNA as a prognostic factor in operable colon cancer patients: a systematic review and meta-analysis. | Yekedüz E, Köksoy EB, Akbulut H, Ürün Y, Utkan G. | Future Oncol. 2021 Jan;17(3):349-357. doi: 10.2217/fon-2020-0671. Epub 2020 Dec 24. | PMID: 33356539 |
| 11 | Intense 18F-Flourodeoxyglucose Uptake in Brachial Plexus of Patients with Brachial Plexopathy. | Soydal Ç, Akkuş P, Araz M, Utkan G. | Mol Imaging Radionucl Ther. 2020 Apr 29;29(2):79-81. doi: 10.4274/mirt.galenos.2019.40469. | PMID: 32368879 |
| 12 | Retrospective analysis of seventy-one patients with neuroendocrine tumor and review of the literature. | Dogan M, Yalcin B, Ozdemir NY, Arslan UY, Dogan L, Utkan G, Akbulut H, Zengin N, Alkis N, Icli F. | Med Oncol. 2012 Sep;29(3):2021-6. doi: 10.1007/s12032-011-9986-9. Epub 2011 May 27. | PMID: 21618056 |
| 13 | Response to letter entitled: Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19. | Yekedüz E, Utkan G, Ürün Y. | Eur J Cancer. 2021 Jul;152:248-249. doi: 10.1016/j.ejca.2021.04.010. Epub 2021 May 17. | PMID: 34016491 |
| 14 | Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: a Dual-Center Study. | Yekedüz E, Dogan İ, Kaya DM, Özgür İ, Utkan G, Vatansever S, Demirci S, Akbulut H, Ürün Y. | J Gastrointest Cancer. 2021 Nov 30. doi: 10.1007/s12029-021-00769-w. Online ahead of print. | PMID: 34845631 |
| 15 | Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real-life data. | Gürbüz M, Doğan İ, Akkuş E, Ermiş H, Utkan G, Vatansever S, Taş F. | Dermatol Ther. 2021 Nov;34(6):e15122. doi: 10.1111/dth.15122. Epub 2021 Sep 12. | PMID: 34478210 |
| 16 | Adjuvant Treatment of Gastric Cancer in the D2 Dissection Era: A Real-life Experience from a Multicenter Retrospective Cohort Study. | Yekedüz E, Doğan İ, Birgi SD, Keskin M, Karaman Ş, Utkan G, Karabulut S, Bayar S, Akbulut H, Demirci S, Akyürek S, Ürün Y. | Euroasian J Hepatogastroenterol. 2021 Jul-Dec;11(2):51-58. doi: 10.5005/jp-journals-10018-1343. | PMID: 34786357 |
| 17 | Assessing population diversity in phase III trials of cancer drugs supporting Food and Drug Administration approval in solid tumors. | Yekedüz E, Trapani D, Xu W, de Vries EGE, Labaki C, Gyawali B, Gulati S, Nabhan C, Utkan G, Curigliano G, Choueiri TK, Ürün Y. | Int J Cancer. 2021 Oct 1;149(7):1455-1462. doi: 10.1002/ijc.33708. Epub 2021 Jul 5. | PMID: 34124786 |
| 18 | The more we use, the more we lose. | Alkan A, Mızrak D, Utkan G. | Med Oncol. 2015 Apr;32(4):123. doi: 10.1007/s12032-015-0569-z. Epub 2015 Mar 19. | PMID: 25788031 No abstract available. |
| 19 | Fifty-one Kaposi sarcoma patients. | Dogan M, Dogan L, Ozdemir F, Ozdemir NY, Coskun HS, Arslan UY, Ozal G, Utkan G, Demirkazik A, Aydin F, Zengin N, Icli F. | Clin Transl Oncol. 2010 Sep;12(9):629-33. doi: 10.1007/s12094-010-0568-7. | PMID: 20851804 |
| 20 | Topical aloe vera for the treatment of cetuximab-related acneiform rash in colorectal cancer: A case report. | Gürbüz M, Akkuş E, Utkan G. | J Oncol Pharm Pract. 2021 Mar;27(2):480-484. doi: 10.1177/1078155220937751. Epub 2020 Jul 5. | PMID: 32623964 |
| 21 | Osteogenesis imperfecta, pseudoachalasia, and gastric cancer. | Mizrak D, Alkan A, Erdogdu B, Utkan G. | Case Rep Gastrointest Med. 2015;2015:685459. doi: 10.1155/2015/685459. Epub 2015 Mar 22. | PMID: 25874139 |
| 22 | First-line crizotinib in ALK-positive lung cancer. | Alkan A, Köksoy EB, Utkan G. | N Engl J Med. 2015 Feb 19;372(8):781-2. doi: 10.1056/NEJMc1415973. | PMID: 25693023 |
| 23 | Prevalence, etiology and risk factors of anemia in patients with newly diagnosed cancer. | Kenar G, Köksoy EB, Ürün Y, Utkan G. | Support Care Cancer. 2020 Nov;28(11):5235-5242. doi: 10.1007/s00520-020-05336-w. Epub 2020 Feb 21. | PMID: 32086566 |
| 24 | Intraabdominal follicular dendritic cell sarcoma: a report of three cases and review of the literature. | Urun Y, Kankaya D, Koral L, Yalcin B, Karabork A, Ceyhan K, Boruban MC, Utkan G, Demirkazik A. | Tumori. 2013 Mar-Apr;99(2):e65-9. doi: 10.1700/1283.14210. | PMID: 23748832 |
| 25 | Sweet’s syndrome under ipilimumab therapy and a brief comparison of the cases in literature. | Yaşar HA, Akkus E, Heper A, Akay BN, Urun Y, Utkan G. | J Oncol Pharm Pract. 2020 Oct;26(7):1762-1764. doi: 10.1177/1078155220906885. Epub 2020 Feb 23. | PMID: 32089071 |
| 26 | Albumin to globulin ratio, a predictor or a misleader? | Alkan A, Köksoy EB, Utkan G. | Ann Oncol. 2015 Feb;26(2):443-4. doi: 10.1093/annonc/mdu554. Epub 2014 Dec 1. | PMID: 25467014 |
| 27 | Can obesity be an advantage for febrile neutropenia? | Alkan A, Bir K, Utkan G. | Ann Oncol. 2015 Feb;26(2):439-40. doi: 10.1093/annonc/mdu531. Epub 2014 Nov 17. | PMID: 25403585 |
| 28 | Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab. | Yekedüz E, Dursun B, Aydın GÇ, Yazgan SC, Öztürk HH, Azap A, Utkan G, Ürün Y. | J Oncol Pharm Pract. 2020 Jul;26(5):1289-1294. doi: 10.1177/1078155220924084. Epub 2020 May 19. | PMID: 32423324 |
| 29 | The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer. | Yasar HA, Bir Yucel K, Arslan C, Ucar G, Karakaya S, Bilgin B, Taban H, Kucukarda A, Erturk I, Hızal M, Yıldız B, Yıldırım N, Demirci U, Sendur MA, Utkan G, Kılıckap S, Cicin I, Karadurmus N, Ürün Y. | J Oncol Pharm Pract. 2020 Jul;26(5):1110-1116. doi: 10.1177/1078155219883004. Epub 2019 Oct 25. | PMID: 31653193 |
| 30 | Journey to a faraway land. | Alkan A, Karcı E, Utkan G. | Ann Oncol. 2015 Oct;26(10):2200. doi: 10.1093/annonc/mdv320. Epub 2015 Jul 23. | PMID: 26205394 |
| 31 | Sweet Syndrome After Autologous Stem Cell Transplant. | Alkan A, İdemen C, Okçu Heper A, Utkan G. | Exp Clin Transplant. 2016 Feb;14(1):109-11. doi: 10.6002/ect.2014.0073. Epub 2015 Mar 3. | PMID: 25748978 |
| 32 | Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors. | Yekedüz E, Utkan G, Ürün Y. | Future Oncol. 2022 Feb;18(4):413-416. doi: 10.2217/fon-2021-1513. Epub 2022 Jan 12. | PMID: 35018793 |
| 33 | A systematic review: Role of systemic therapy on treatment and prevention of brain metastasis in renal cell carcinoma. | Yekedüz E, Arzu Yaşar H, Utkan G, Ürün Y. | J Oncol Pharm Pract. 2020 Jun;26(4):972-981. doi: 10.1177/1078155220905648. Epub 2020 Feb 25. | PMID: 32098554 |
| 34 | Prognostic factors for survival in patients with mucosal and ocular melanoma treated with ipilimumab: Turkish Oncology Group study. | Arzu Yaşar H, Turna H, Esin E, Murat Sedef A, Alkan A, Oksuzoglu B, Ozdemir N, Sendur MN, Sezer A, Kılıckap S, Utkan G, Akbulut H, Celik I, Abalı H, Urun Y. | J Oncol Pharm Pract. 2020 Mar;26(2):267-272. doi: 10.1177/1078155219840796. Epub 2019 Mar 29. | PMID: 30924738 |
| 35 | Radiation-Induced Tumor Lysis Syndrome in Chronic Lymphocytic Leukemia. | Alkan A, Kütük T, Karcı E, Yaşar A, Hiçsönmez A, Utkan G. | Turk J Haematol. 2016 Sep 5;33(3):248-50. doi: 10.4274/tjh.2015.0259. Epub 2016 Apr 18. | PMID: 27093891 |
| 36 | Widespread Metastatic Prostate Carcinoma Shown by 68Ga-PSMA PET/CT. | Soydal C, Ozkan E, Yerlikaya H, Utkan G, Kucuk ON. | Clin Nucl Med. 2016 Jun;41(6):e294-5. doi: 10.1097/RLU.0000000000001176. | PMID: 26909710 |
| 37 | Diagnostic serum vitamin D level is not a reliable prognostic factor for resectable breast cancer. | Mizrak Kaya D, Ozturk B, Kubilay P, Onur H, Utkan G, Cay Senler F, Alkan A, Yerlikaya H, Koksoy EB, Karci E, Demirkazik A, Akbulut H, Icli F. | Future Oncol. 2018 Jun;14(15):1461-1467. doi: 10.2217/fon-2017-0608. Epub 2018 May 9. | PMID: 29741392 |
| 38 | Lower folate levels in gastric cancer: is it a cause or a result? | Alkan A, Mızrak D, Utkan G. | World J Gastroenterol. 2015 Apr 7;21(13):4101-2. doi: 10.3748/wjg.v21.i13.4101. | PMID: 25852300 |
| 39 | Malign peritoneal mesothelioma with nephrotic syndrome. | Dogan M, Ozal G, Savas B, Gungor M, Utkan G, Yalcin B, Icli F. | Bratisl Lek Listy. 2012;113(1):43-5. doi: 10.4149/bll_2012_010. | PMID: 22380502 |
| 40 | Multidisciplinary management of lung cancer. | Buyukcelik A, Yalcin B, Utkan G. | N Engl J Med. 2004 May 6;350(19):2008-10; author reply 2008-10. | PMID: 15131843 |
| 41 | IgA lambda oligoclonal gammopathy in multiple myeloma. | Tek İ, Mızrak D, Utkan G, Koçak Toprak S, Tutkak H, Büyükçelik A, Yalçın B, Akbulut H, İçli F. | Turk J Haematol. 2010 Jun 5;27(2):126-7. doi: 10.5152/tjh.2010.14. | PMID: 27263458 |
| 42 | Comparison of Gemcitabine monotherapy with Gemcitabine and Cisplatin combination in metastatic pancreatic cancer: a retrospective analysis. | Ergun Y, Ozdemir NY, Guner EK, Esin E, Sendur MA, Koksoy EB, Demirci NS, Eren T, Dede I, Sezer A, Engin H, Oksuzoglu B, Yalcin B, Utkan G, Zengin N, Urun Y. | J BUON. 2018 Dec;23(7):116-121. | PMID: 30722120 |
| 43 | Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study. | Urun Y, Yasar HA, Turna H, Esin E, Sedef AM, Alkan A, Oksuzoglu B, Ozdemir N, Sendur MN, Sezer A, Kılıckap S, Utkan G, Akman T, Akbulut H, Celik I, Abalı H. | J Oncol Pharm Pract. 2019 Oct;25(7):1658-1664. doi: 10.1177/1078155218805539. Epub 2018 Nov 6. | PMID: 30400750 |
| 44 | The clinicopathological characteristics with long-term outcomes in malignant mesothelioma. | Dogan M, Utkan G, Hocazade C, Uncu D, Toptas S, Ozdemir N, Zengin N, Icli F. | Med Oncol. 2014 Oct;31(10):232. doi: 10.1007/s12032-014-0232-0. Epub 2014 Sep 11. | PMID: 25208819 |
| 45 | The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib. | Yekedüz E, Aktaş EG, Köksoy EB, Doğan N, Ürün Y, Utkan G. | Future Oncol. 2022 Mar;18(9):1067-1076. doi: 10.2217/fon-2021-1182. Epub 2022 Feb 3. | PMID: 35109668 |
| 46 | Cetuximab related eyelash elongations for patients with metastatic rectum carcinoma: metabolic complete response. | Urün Y, Utkan G. | Ann Dermatol. 2013 Nov;25(4):504-5. doi: 10.5021/ad.2013.25.4.504. Epub 2013 Nov 30. | PMID: 24371405 |
| 47 | The significance of serum leptin level in patients with early stage nonsmall cell lung cancer. | Karatas F, Yalcin B, Sahin S, Akbulut H, Utkan G, Demirkazik A, Icli F. | J Cancer Res Ther. 2017 Apr-Jun;13(2):204-207. doi: 10.4103/0973-1482.196859. | PMID: 28643734 |
| 48 | Lung cancer metastasis mimicking gluteal abscess. | Tek I, Iyidir OT, Utkan G, Ceyhan K, Buyukcelik A, Yalcin B, Demirkazik A. | South Med J. 2007 Mar;100(3):334-5. doi: 10.1097/SMJ.0b013e31802ffa07. | PMID: 17402150 |
| 49 | Relationship between antimetabolite toxicity and pharmacogenetics in Turkish cancer patients. | Dogan M, Karabulut HG, Tukun A, Demirkazik A, Utkan G, Yalcin B, Dincol D, Akbulut H, Icli F. | Asian Pac J Cancer Prev. 2012;13(4):1553-6. doi: 10.7314/apjcp.2012.13.4.1553. | PMID: 22799365 |
| 50 | ABO and Rh blood groups and risk of colorectal adenocarcinoma. | Urun Y, Ozdemir NY, Utkan G, Akbulut H, Savas B, Oksuzoglu B, Oztuna DG, Dogan I, Yalcin B, Senler FC, Onur H, Demirkazik A, Zengin N, Icli F. | Asian Pac J Cancer Prev. 2012;13(12):6097-100. doi: 10.7314/apjcp.2012.13.12.6097. | PMID: 23464411 |
| 51 | The role of cardiac biomarkers as predictors of trastuzumab cardiotoxicity in patients with breast cancer. | Ürun Y, Utkan G, Yalcin B, Akbulut H, Onur H, Oztuna DG, Şenler FC, Demirkazık A, İçli F. | Exp Oncol. 2015 Mar;37(1):53-7. | PMID: 25804233 |
| 52 | A rare gastric neoplasm: gastric medullary carcinoma. | Dogan M, Savas B, Utkan G, Bayar S, Ensari A, Icli F. | Med Oncol. 2011 Dec;28(4):945-7. doi: 10.1007/s12032-010-9557-5. Epub 2010 May 11. | PMID: 20458556 |
| 53 | Medication errors in chemotherapy preparation and administration: a survey conducted among oncology nurses in Turkey. | Ulas A, Silay K, Akinci S, Dede DS, Akinci MB, Sendur MA, Cubukcu E, Coskun HS, Degirmenci M, Utkan G, Ozdemir N, Isikdogan A, Buyukcelik A, Inanc M, Bilici A, Odabasi H, Cihan S, Avci N, Yalcin B. | Asian Pac J Cancer Prev. 2015;16(5):1699-705. doi: 10.7314/apjcp.2015.16.5.1699. | PMID: 25773812 |
| 54 | Primary extranodal non-Hodgkin’s lymphoma presenting as painful gingival swelling. | Ürün Y, Can F, Bariş E, Akbulut H, Utkan G, İçli F. | Exp Oncol. 2012 Jul;34(2):134-5. | PMID: 23013768 |
| 55 | Optimal timing of adjuvant treatment in patients with early breast cancer. | Alkis N, Durnali AG, Arslan UY, Kocer M, Onder FO, Tokluoglu S, Celenkoglu G, Muallaoglu S, Utkan G, Ulas A, Altundag K. | Med Oncol. 2011 Dec;28(4):1255-9. doi: 10.1007/s12032-010-9566-4. Epub 2010 May 15. | PMID: 20473647 |
| 56 | Association of ABO blood group and risk of lung cancer in a multicenter study in Turkey. | Urun Y, Utkan G, Cangir AK, Oksuzoglu OB, Ozdemir N, Oztuna DG, Kocaman G, Coşkun HŞ, Kaplan MA, Yuksel C, Demirkazik A, Icli F. | Asian Pac J Cancer Prev. 2013;14(5):2801-3. doi: 10.7314/apjcp.2013.14.5.2801. | PMID: 23803034 |
| 57 | Activity of pemetrexed on brain metastases from non-small cell lung cancer: what is the mechanism? | Dogan M, Yalcin B, Utkan G, Urun Y, Ozal G. | Lung Cancer. 2009 Dec;66(3):399. doi: 10.1016/j.lungcan.2009.09.004. Epub 2009 Sep 24. | PMID: 19783320 |
| 58 | Perception about influenza and pneumococcal vaccines and vaccination coverage among patients with malignancies and their family members. | Urun Y, Akbulut H, Demirkazik A, Cay Senler F, Utkan G, Onur H, Icli F. | J BUON. 2013 Apr-Jun;18(2):511-5. | PMID: 23818370 |
| 59 | Divided dose of cisplatin combined with gemcitabine in malignant mesothelioma. | Utkan G, Büyükçelik A, Yalçin B, Akbulut H, Demirkazik A, Dinçol D, Onur H, Gören D, Mousa U, Senler FC, Içli F. | Lung Cancer. 2006 Sep;53(3):367-74. doi: 10.1016/j.lungcan.2006.04.014. Epub 2006 Jul 7. | PMID: 16828196 |
| 60 | Clinicopathological features of patients with malignant mesothelioma in a multicenter, case-control study: no role for ABO-Rh blood groups. | Utkan G, Ürün Y, Cangir AK, Kılıç D, Özdemir NY, Oztuna DG, Bulut E, Arslan ÜY, Koçer M, Kavukçu Ş, İçli F. | Asian Pac J Cancer Prev. 2013;14(1):249-53. | PMID: 23534732 |
| 61 | Extranodal Hodgkin disease presenting with gluteal mass and hypercalcemia. | Utkan G, Buyukcelik A, Yalcin B, Tek I, Doruk H, Dincol D, Erekul S, Baykara M. | South Med J. 2006 Oct;99(10):1149-50. doi: 10.1097/01.smj.0000240720.24001.77. | PMID: 17100047 |
| 62 | Kikuchi–Fujimoto disease: cervical lymphadenopathy suggestive of relapsing lymphoma in patient with lymphoblastic lymphoma. | Urun Y, Utkan G, Kankaya D, Dogan M, Yalcin B, İcli F. | Exp Oncol. 2011 Dec;33(4):242-4. | PMID: 22217716 |
| 63 | Re: Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene. | Yalcin B, Buyukcelik A, Yalcin S, Utkan G, Doruk H, Dogan M, Altan M. | J Natl Cancer Inst. 2005 Apr 6;97(7):542; author reply 542-3. doi: 10.1093/jnci/dji090. | PMID: 15812082 |
| 64 | Lack of any relationship between ABO and Rh blood groups and clinicopathological features in patients with gastrointestinal stromal tumors: Turkish Oncology Group. | Ürün Y, Utkan G, Yalcin Ş, Coşkun HŞ, Koçer M, Özdemir NY, Kaplan MA, Arslan ÜY, Özdemir F, Öztuna D, Akbulut H, İçli F. | Asian Pac J Cancer Prev. 2012;13(8):4129-31. | PMID: 23098529 |
| 65 | The efficacy and safety of oral ibandronate in the treatment of metastatic bone disease in patients with breast cancer. | Utkan G, Büyükçelik A, Yalçyn B. | Ann Oncol. 2004 Oct;15(10):1574; author reply 1574-5. doi: 10.1093/annonc/mdh396. | PMID: 15367420 |
| 66 | Low molecular weight heparin (LMWH) increases the efficacy of cisplatinum plus gemcitabine combination in advanced pancreatic cancer. | Icli F, Akbulut H, Utkan G, Yalcin B, Dincol D, Isikdogan A, Demirkazik A, Onur H, Cay F, Büyükcelik A. | J Surg Oncol. 2007 May 1;95(6):507-12. doi: 10.1002/jso.20728. | PMID: 17192920 |
| 67 | Is obesity always a risk factor for all breast cancer patients? c-erbB2 expression is significantly lower in obese patients with early stage breast cancer. | Mousa U, Onur H, Utkan G. | Clin Transl Oncol. 2012 Dec;14(12):923-30. doi: 10.1007/s12094-012-0878-z. Epub 2012 Jul 25. | PMID: 22855166 |
| 68 | Intracranial aggressive fibromatosis presenting as panhypopituitarism and diabetes insipidus. | Gursoy A, Cesur M, Aktaş B, Utkan G, Gedik VT, Erdogan M, Kamel N. | Pituitary. 2005;8(2):123-6. doi: 10.1007/s11102-005-3758-5. | PMID: 16379037 |
| 69 | Thrombosis of the pulmonary artery in a patient with mucinous adenocarcinoma. | Buyukcelik A, Bulent Y, Utkan G, Icli F, Sanlidilek U, Akbulut H. | Med Sci Monit. 2006 Sep;12(9):CS90-3. | PMID: 16940937 |
| 70 | Relation between the duration of remission and hyperglycemia during induction chemotherapy for acute lymphoblastic leukemia with a hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone/methotrexate-cytarabine regimen. | Büyükçelik A, Yalçin B, Utkan G, Doruk H. | Cancer. 2004 Sep 1;101(5):1100-1; author reply 1101. doi: 10.1002/cncr.20461. | PMID: 15329922 |
| 71 | high-dose ifosfamide with hematopoietic growth factor support in advanced bone and soft tissue sarcomas. | Yalcin B, Pamir A, Buyukcelik A, Utkan G, Akbulut H, Demirkazik A, Icli F. | Exp Oncol. 2004 Dec;26(4):320-5. | PMID: 15627067 |
| 72 | Expression of Cox-2 protein in radioresistant laryngeal cancer. | Yalcin B, Büyükçelik A, Utkan G. | Ann Oncol. 2004 Nov;15(11):1721; author reply 1721-2. doi: 10.1093/annonc/mdh439. | PMID: 15520079 |
| 73 | ABO and Rh blood groups frequency in women with HER2 positive breast cancer. | Urun Y, Utkan G, Altundag K, Arslan O, Onur H, Arslan UY, Kocer M, Dogan I, Senler FC, Yalcin B, Demirkazik A, Akbulut H, Icli F. | J BUON. 2012 Jul-Sep;17(3):457-60. | PMID: 23033281 |
| 74 | A thermo-sensitive NIPA-based co-polymer and monosize polycationic nanoparticle for non-viral gene transfer to smooth muscle cells. | Laçin NT, Utkan GG, Kutsal T, Pişkin E. | J Biomater Sci Polym Ed. 2012;23(5):577-92. doi: 10.1163/092050611X555272. Epub 2011 Feb 10. | PMID: 21310109 |
| 75 | Solid pseudopapillary tumor of the pancreas: a case series of 7 patients. | Urun Y, Kepenekci I, Tuzuner A, Dogan M, Erden E, Utkan G, Icli F. | J BUON. 2012 Jul-Sep;17(3):600-1. | PMID: 23033308 |
| 76 | Fine needle aspiration biopsy features with histologic correlation in mediastinal hepatoid yolk sac tumor presenting with sternum metastasis: a case report. | Ceyhan K, Utkan G, Dincol D, Erdogan N, Erekul S, Umudum H. | Acta Cytol. 2007 Jul-Aug;51(4):610-5. doi: 10.1159/000325809. | PMID: 17718136 |
| 77 | Adjuvant chemotherapy for lung cancer. | Büyükçelik A, Utkan G, Yalçin B. | N Engl J Med. 2004 Apr 15;350(16):1681-3; author reply 1681-3. | PMID: 15088318 |
| 78 | Survival following the documentation of platinum and taxane resistance in ovarian cancer. | Büyükçelik A, Yalçin B, Utkan G, Doruk H. | Gynecol Oncol. 2004 Dec;95(3):774-5; author reply 775-6. doi: 10.1016/j.ygyno.2004.08.013. | PMID: 15582006 |
| 79 | Alpha fetoprotein producing gastric hepatoid adenocarcinoma. | Utkan G, Büyükçelik A, Ceyhan K, Ortabozkoyun L, Tek I, Yalçin B, Dinçol D. | J Pak Med Assoc. 2006 Jun;56(6):292-4. | PMID: 16827258 |
| 80 | Blood viscosity in patients with diffuse large B cell non-Hodgkin’s lymphoma. | Utkan G, Tek I, Kocer M, Muallaoglu S, Durnal AG, Arslan UY, Celenkoglu G, Tokluoglu S, Alkis N. | Exp Oncol. 2006 Dec;28(4):326-7. | PMID: 17285120 |
| 81 | Expression of p53 protein and DNA flow cytometry in gastric adenocarcinoma: implications in patients treated with adjuvant etoposide, adriamycin and cisplatin. | Büyükçelik A, Onur H, Akbulut H, Bülent Y, Ensari A, Utkan G, Onal BS, Içli F. | Tumori. 2005 Jul-Aug;91(4):302-8. | PMID: 16277093 |
| 82 | The effect of venous thromboembolism on survival of cancer patients and its relationship with serum levels of factor VIII and vascular endothelial growth factor: a prospective matched-paired study. | Dogan M, Demirkazik A, Konuk N, Yalcin B, Buyukcelik A, Utkan G, Tek I, Akbulut H, Sencan O, Icli F. | Int J Biol Markers. 2006 Oct-Dec;21(4):206-10. | PMID: 17177157 |
| 83 | The effect of venous thromboembolism on survival of cancer patients and its relationship with serum levels of factor VIII and vascular endothelial growth factor: a prospectivematched-paired study. | Dogan M, Demirkazik A, Konuk N, Yalcin B, Buyukcelik A, Utkan G, Tek I, Akbulut H, Sencan O, Icli F. | Int J Biol Markers. 2006 Oct-Dec;21(4):206-210. doi: 10.5301/JBM.2008.4592. | PMID: 28207147 |
| 84 | Combination chemotherapy of gemcitabine and vinorelbine in patients with advanced non-small cell lung cancer. | Buyukcelik A, Utkan G, Yalcin B, Demirkazik A. | Lung Cancer. 2004 Dec;46(3):377-8. doi: 10.1016/j.lungcan.2004.03.024. | PMID: 15541824 |
| 85 | Two cases with atypical metastasis in colorectal cancer: splenic and renal metastasis. | Dogan M, Ozal G, Ekinci C, Utkan G, Urun Y, Yalcin B, Icli F. | Exp Oncol. 2010 Dec;32(4):277-9. | PMID: 21270759 |
| 86 | Synthesis and characterization of nanomagnetite particles and their polymer coated forms. | Utkan GG, Sayar F, Batat P, Ide S, Kriechbaum M, Pişkin E. | J Colloid Interface Sci. 2011 Jan 15;353(2):372-9. doi: 10.1016/j.jcis.2010.09.081. Epub 2010 Oct 29. | PMID: 21035815 |
| 87 | Post-transfusion acute graft versus host disease in a 17-year-old girl with a malignant mesenchymal tumor–report of a case. | Utkan G, Buyukcelik A, Demir O, Sanli H, Pamir A. | Acta Med Austriaca. 2003;30(5):138-41. | PMID: 15055161 |
| 88 | Treatment of advanced head and neck cancer. | Yalçýn B, Büyükçelik A, Utkan G. | N Engl J Med. 2004 Aug 19;351(8):829-31; author reply 829-31. | PMID: 15320314 |
| 89 | Angiotensin-converting enzyme inhibitors: do they contribute to delayed chemotherapy induced nausea and vomiting? | Dogan M, Yalcin B, Ozal FG, Buyukcelik A, Utkan G, Icli F, Dogan L. | Med Hypotheses. 2009 Oct;73(4):628-9. doi: 10.1016/j.mehy.2009.06.028. Epub 2009 Jul 23. | PMID: 19631476 |
| 90 | Solid tumors in patients treated for Hodgkin’s disease. | Utkan G, Büyükçelik A, Yalçin B. | Ann Oncol. 2004 Dec;15(12):1848-9. doi: 10.1093/annonc/mdh481. | PMID: 15550593 |
| 91 | Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma: is it safe? | Utkan G, Yalçin B, Büyükçelik A, Yalçin S. | J Clin Oncol. 2005 Jan 20;23(3):655; author reply 655. doi: 10.1200/JCO.2005.05.259. | PMID: 15659523 |
| 92 | Activity of irinotecan, cisplatin and dacarbazine (CPD) combination in previously treated patients with advanced colorectal carcinoma. | Akbulut H, Icli F, Yalcin B, Demirkazik A, Onur H, Buyukcelik A, Utkan G. | Exp Oncol. 2004 Jun;26(2):149-52. | PMID: 15273666 |
| 93 | Non-Hodgkin’s lymphoma of the female urethra presenting as a caruncle. | Atalay AC, Karaman MI, Basak T, Utkan G, Ergenekon E. | Int Urol Nephrol. 1998;30(5):609-10. doi: 10.1007/BF02550554. | PMID: 9934806 |
Bilimsel Yayınlaradmin2022-07-20T12:31:08+00:00
